By James Huang, Research Analyst, LSN

With medical technology entrepreneurs facing a challenging capital landscape, angel capital remains a vital source of early stage funding in the sector. According to studies by the Angel Resource Institute, of every angel dollar invested in the USA, nearly 20 cents goes into healthcare and life sciences. In recognition of the importance of angel financing to early stage companies, RESI features two angel panels, and today we would like to announce our Medtech Angels panel for RESI Boston. If you’re interested in how to pitch to an angel group, what makes a medtech opportunity suitable for angel investment, or how angels work with their portfolio companies to hit subsequent milestones and follow-on raises, this panel is for you.
LSN has brought together five highly experienced angels who have a focus on medical technology investment. The participants are:
- Laura Davis – Managing Director, Golden Seeds
- Eric Dobson – CEO, Angel Capital Group
- Harald Stock – Managing Partner, Alta Life Science
- Bernie Rudnick – Founding Member, Mid Atlantic Bio Angels
- Bob Williams – Angel Investor, Life Sciences Angel Network






